L-lactide（LLA） homopolymerization and copolymerization with ε-caprolactone（CL） in toluene initiated by tetrahydrosalen-supported yttrium borohydride complex were systematically investigated. A possible mechanism ...L-lactide（LLA） homopolymerization and copolymerization with ε-caprolactone（CL） in toluene initiated by tetrahydrosalen-supported yttrium borohydride complex were systematically investigated. A possible mechanism of LLA homopolymerization was proposed according to the 1H-NMR result. In addition, PCL-b-PLLA copolymers were synthesized by sequential addition of monomers and their structure was characterized by GPC, 1H-NMR and 13C-NMR.展开更多
The solid forms of drugs play a central role in controlling their physicochemical properties and consequently the bioavailability. Multiple types of drug solid forms have been developed to achieve the desirable pharma...The solid forms of drugs play a central role in controlling their physicochemical properties and consequently the bioavailability. Multiple types of drug solid forms have been developed to achieve the desirable pharmaceutical profiles, but new solid forms will provide more options for the solid-state property optimization and hence are highly desirable. This review focuses on a new pharmaceutical solid form, drug-polymer inclusion complexes （ICs）, and summarizes their structural features, structure- property relationships, as well as potential pharmaceutical applications展开更多
基金supported by the National Natural Science Foundation of China(No.21174129)the Program for Zhejiang Leading Teams of S&T Innovation(2011R50007)
文摘L-lactide（LLA） homopolymerization and copolymerization with ε-caprolactone（CL） in toluene initiated by tetrahydrosalen-supported yttrium borohydride complex were systematically investigated. A possible mechanism of LLA homopolymerization was proposed according to the 1H-NMR result. In addition, PCL-b-PLLA copolymers were synthesized by sequential addition of monomers and their structure was characterized by GPC, 1H-NMR and 13C-NMR.
基金supported by the National Natural Science Foundation of China (No. 21434008)
文摘The solid forms of drugs play a central role in controlling their physicochemical properties and consequently the bioavailability. Multiple types of drug solid forms have been developed to achieve the desirable pharmaceutical profiles, but new solid forms will provide more options for the solid-state property optimization and hence are highly desirable. This review focuses on a new pharmaceutical solid form, drug-polymer inclusion complexes （ICs）, and summarizes their structural features, structure- property relationships, as well as potential pharmaceutical applications
